Cite

HARVARD Citation

    Rodionov, R. et al. (2017). ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathy. Atherosclerosis. pp. 319-325. [Online]. 
  
Back to record